Production of a high purity, C-tagged Hepatitis B surface Antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
Journal article
Mukhopadhyay E. et al, (2022), Biotechnology and bioengineering
Ancient DNA reveals five streams of migration into Micronesia and matrilocality in early Pacific seafarers.
Journal article
Liu Y-C. et al, (2022), Science (New York, N.Y.), 377, 72 - 79
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.
Journal article
Bastard P. et al, (2022), The Journal of experimental medicine, 219
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
Viral Vectors Expressing Group B Meningococcal Outer Membrane Proteins Induce Strong Antibody Responses but Fail to Induce Functional Bactericidal Activity in Mice.
Journal article
Marsay L. et al, (2022), The Journal of infection
CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
Journal article
Sharpe HR. et al, (2022), JCI Insight
Publisher Correction: Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.
Journal article
Dulal P. et al, (2021), Scientific reports, 11
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Journal article
Feng S. et al, (2021), Nature Medicine, 27, 2032 - 2040
Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation.
Journal article
Dulal P. et al, (2021), Scientific reports, 11
Paths and timings of the peopling of Polynesia inferred from genomic networks.
Journal article
Ioannidis AG. et al, (2021), Nature, 597, 522 - 526
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.
Journal article
McAuliffe J. et al, (2021), J Immunother Cancer, 9
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article
Flaxman A. et al, (2021), The Lancet, 398, 981 - 990
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trial
Journal article
Clemens SC. et al, (2021)
Dissection-independent production of Plasmodium sporozoites from whole mosquitoes.
Journal article
Blight J. et al, (2021), Life science alliance, 4
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.
Journal article
Collins KA. et al, (2021), Scientific reports, 11
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Journal article
Datoo MS. et al, (2021), The Lancet, 397, 1809 - 1818
A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development.
Journal article
Atcheson E. et al, (2021), NPJ vaccines, 6